atenolol has been researched along with Anemia, Iron-Deficiency in 1 studies
Atenolol: A cardioselective beta-1 adrenergic blocker possessing properties and potency similar to PROPRANOLOL, but without a negative inotropic effect.
atenolol : An ethanolamine compound having a (4-carbamoylmethylphenoxy)methyl group at the 1-position and an N-isopropyl substituent.
Anemia, Iron-Deficiency: Anemia characterized by decreased or absent iron stores, low serum iron concentration, low transferrin saturation, and low hemoglobin concentration or hematocrit value. The erythrocytes are hypochromic and microcytic and the iron binding capacity is increased.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Corwin, DJ | 1 |
| Scarfone, RJ | 1 |
1 review available for atenolol and Anemia, Iron-Deficiency
| Article | Year |
|---|---|
Supraventricular Tachycardia Associated With Severe Anemia.
Topics: Anemia, Iron-Deficiency; Anti-Arrhythmia Agents; Atenolol; Child; Diagnosis, Differential; Electroca | 2018 |